STOCKHOLDERS' EQUITY | NOTE 10 - STOCKHOLDERS' EQUITY As of June 30, 2022, there were 5,594,156,736 Preferred Stock In accordance with the Company’s Certificate of Incorporation, the Company has authorized a total of 2,000,000 0.01 88,335 88,235 On June 22, 2022, the Board of Directors of the Company approved the filing of an amendment to the Company’s Certificate of Incorporation (the “Certificate of Incorporation”), in the form of a Certificate of Designation that authorized for issuance of up to 100 shares of a new series of Preferred Stock, par value $ 0.01 2,000,000 0.01 The holders of the Series A Preferred Stock shall be entitled to vote, on a pro-rata basis, on all matters subject to a vote or written consent of the holders of the Company’s Common Stock, and on all such matters, the shares of Series A Preferred Stock shall be entitled to that number of votes equal to the number of votes that all issued and outstanding shares of Common Stock and all other securities of the Company are entitled to, as of any such date of determination, on a fully diluted basis, plus Unless approved by a majority vote of the holders of Common Stock, the Series A Super Voting Preferred Stock will terminate five years after the issuance date, which is June 24, 2027. During the three months ended June 30, 2022, the Company issued 100 shares of Series A preferred stock. Common Stock In accordance with the Company’s bylaws, the Company has authorized a total of 20,000,000,000 0.0001 5,594,156,736 5,197,821,885 During the three months ended June 30, 2022, the Company issued the following shares of common stock: On January 12, 2022, the Company issued 23,372,430 1,150,000 On January 21, 2022, the Company issued 33,454,988 1,150,000 On February 7, 2022, the Company issued 16,040,411 500,000 On March 3, 2022, the Company issued 16,579,569 500,000 On March 7, 2022, the Company issued 75,798,921 2,500,000 On March 14, 2022, the Company issued 5,617,347 400,000 On March 23, 2022, the Company issued 29,257,395 1,500,000 On April 1, 2022, the Company issued 3,725,386 200,000 On April 8, 2022, the Company issued 23,746,816 1,000,000 On May 3, 2022, the Company issued 29,522,276 1,000,000 On May 13, 2022, the Company issued 26,100,979 556,750 On May 23, 2022, the Company issued 25,025,540 556,750 On June 1, 2022, the Company issued 25,901,921 556,750 On June 16, 2022, the Company issued 23,799,766 402,086 On June 24, 2022, the Company issued 38,391,106 643,539 Stock Options During the three months ended June 30, 2022, the Company did not issue any stock options and had no Public Offerings On November 9, 2021, we entered an Equity Financing Agreement (the “ Equity Financing Agreement GHS Registration Rights Agreement 30,000,000 Contract Period Registration Statement The GHS Registration Rights Agreement provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed. Pursuant to the Equity Financing Agreement, on January 12, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 23,372,430 1,150,000 Second EFA Closing 1,033,975 Pursuant to the Equity Financing Agreement, on January 21, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 33,454,988 1,150,000 Third EFA Closing 1,033,975 Pursuant to the Equity Financing Agreement, on February 7, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 16,040,411 500,000 Fourth EFA Closing 448,975 On February 21, 2022, we sold 75,798,921 2,500,000 On March 3, 2022, we sold 16,579,569 500,000 On March 14, 2022, we sold 5,617,347 400,000 Pursuant to the Equity Financing Agreement, on March 23, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 29,257,395 1,500,000 Fifth EFA Closing 1,348,975 Pursuant to the Equity Financing Agreement, on April 11, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 23,746,816 1,000,000 Sixth EFA Closing 898,975 Pursuant to the Equity Financing Agreement, on May 3, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 29,522,276 1,000,000 Seventh EFA Closing 898,975 Pursuant to the Equity Financing Agreement, on May 13, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 26,100,979 556,750 Eighth EFA Closing 500,050 Pursuant to the Equity Financing Agreement, on May 23, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 25,025,540 556,750 Ninth EFA Closing 500,050 Pursuant to the Equity Financing Agreement, on June 1, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 25,901,921 556,750 Tenth EFA Closing 500,050 Pursuant to the Equity Financing Agreement, on June 16, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 23,799,766 402,086 Eleventh EFA Closing 360,852 On May 27, 2022, we entered an Equity Financing Agreement (the “ EFA RRA 70,000,000 Registration Statement The RRA provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed. Pursuant to the EFA, on June 24, 2022, we and GHS agreed that the Company would issue and sell to GHS, and GHS would purchase from us, 38,391,106 643,539 1 st 578,160 st st |